Search

    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    kntvtelugu
    kntvtelugu

    New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study

    2 hours ago

    PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack of effective drugs forces patients to undergo liver transplantation, because 50 percent of them will require this procedure between 10 to 18 years after their initial diagnosis
    Click here to Read More
    Previous Article
    'Retta Thala' Twitter review: Arun Vijay’s dual act GETS PRAISED
    Next Article
    'Pragg is third favourite': Carlsen rates Candidates 2026 line-up

    Related Life & Style Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment